Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines

References

• Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85; PMID:15692063; http://dx.doi.org/10.1182/blood-2004-09-3502
   PubMed Web of Science ®Google Scholar
• Alsaleh QA, Nanda A, Al-Ajmi H, Al-Sabah H, Elkashlan M, Al-Shemmari S, Demierre MF. Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006. Int J Dermatol 2010; 49:1393-8; PMID:21155090; http://dx.doi.org/10.1111/j.1365-4632.2010.04567.x
   PubMed Web of Science ®Google Scholar
• Sun G, Berthelot C, Li Y, Glass DA, 2nd, George D, Pandya A, Kurzrock R, Duvic M. Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides. J Am Acad Dermatol 2009; 60:231-5; PMID: 19026464; http://dx.doi.org/10.1016/j.jaad.2008.09.063
   PubMed Web of Science ®Google Scholar
• Wilson LD, Hinds GA, Yu JB. Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk 2012; 12:291-6; PMID: 23040434; http://dx.doi.org/10.1016/j.clml.2012.06.010
   PubMed Web of Science ®Google Scholar
• Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007; 143:854-9; PMID: 17638728; http://dx.doi.org/10.1001/archderm.143.7.854
   PubMed Web of Science ®Google Scholar
• Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers. JAm Acad Dermatol 2014; 70:205 e1-16; quiz 21-2; PMID: 24355276; http://dx.doi.org/10.1016/j.jaad.2013.08.033
   PubMed Web of Science ®Google Scholar
• Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 2010; 116:767-71; PMID:20484084; http://dx.doi.org/10.1182/blood-2009-11-251926
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Jones DA, Sasseville D, Kupper TS. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma. Clin cancer res : an official j Am Assoc Cancer Res 2010; 16:2106-14; PMID:20233883; http://dx.doi.org/10.1158/1078-0432.CCR-09-2879
   PubMed Web of Science ®Google Scholar
• Shin J, Monti S, Aires DJ, Duvic M, Golub T, Jones DA, Kupper TS. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood 2007; 110:3015-27; PMID:17638852; http://dx.doi.org/10.1182/blood-2006-12-061507
   PubMed Web of Science ®Google Scholar
• van Kester MS, Borg MK, Zoutman WH, Out-Luiting JJ, Jansen PM, Dreef EJ, Vermeer MH, van Doorn R, Willemze R, Tensen CP. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides. J invest dermatol 2012; 132:2050-9; PMID: 22513784; http://dx.doi.org/10.1038/jid.2012.117
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Cordeiro B, Huang Y, Zargham H, Pehr K, Dore MA, Gilbert M, Zhou Y, Kupper TS, Sasseville D. Ectopic expression of cancer testis antigens in Cutaneous T-Cell Lymphoma (CTCL) patients. Clin Cancer Res. 2014; 20(14):3799-808; PMID:24850846; http://dx.doi.org/10.1158/1078-0432.CCR-14-0307
   PubMed Web of Science ®Google Scholar
• Dobbeling U. Transcription factor profiling shows new ways towards new treatment options of cutaneous T cell lymphomas. Curr drug discov technol 2007; 4:24-30; PMID:17630925; http://dx.doi.org/10.2174/157016307781115467
   PubMedGoogle Scholar
• Qin JZ, Kamarashev J, Zhang CL, Dummer R, Burg G, Dobbeling U. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J invest dermatol 2001; 117:583-9; PMID: 11564163; http://dx.doi.org/10.1046/j.0022-202x.2001.01436.x
   PubMed Web of Science ®Google Scholar
• Qin JZ, Zhang CL, Kamarashev J, Dummer R, Burg G, Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 2001; 98:2778-83; PMID:11675351; http://dx.doi.org/10.1182/blood.V98.9.2778
   PubMed Web of Science ®Google Scholar
• Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, Jønson L, Hagedorn PH, Krejsgaard T, Gniadecki R. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell cycle 2013; 12:1939-47; PMID: 23676217; http://dx.doi.org/10.4161/cc.24987
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Pehr K, Sasseville D. Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155. Cell cycle 2013; 12:2172-3; PMID:23803726; http://dx.doi.org/10.4161/cc.25550
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Nat Acad Sci U S A 2011; 108:4908-13; PMID:21383199; http://dx.doi.org/10.1073/pnas.1101795108
   PubMed Web of Science ®Google Scholar
• Tracey L, Villuendas R, Dotor AM, Spiteri I, Ortiz P, Garcia JF, Peralto JL, Lawler M, Piris MA. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003; 102:1042-50; PMID:12689942; http://dx.doi.org/10.1182/blood-2002-11-3574
   PubMed Web of Science ®Google Scholar
• Johnson VE, Vonderheid EC, Hess AD, Eischen CM, McGirt LY. Genetic markers associated with progression in early mycosis fungoides. J Eur Acad Dermatol Venereol 2013; PMID:24171863; http://dx.doi.org/10.1111/jdv.12299
   PubMed Web of Science ®Google Scholar
• Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J. et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. The J exp med 2003; 197:1477-88; PMID:12782714; http://dx.doi.org/10.1084/jem.20021726
   PubMed Web of Science ®Google Scholar
• Nebozhyn M, Loboda A, Kari L, Rook AH, Vonderheid EC, Lessin S, Berger C, Edelson R, Nichols C, Yousef M. et al. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy. Blood 2006; 107:3189-96; PMID:16403914; http://dx.doi.org/10.1182/blood-2005-07-2813
   PubMed Web of Science ®Google Scholar
• Showe LC, Fox FE, Williams D, Au K, Niu Z, Rook AH. Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J immunol 1999; 163:4073-9; PMID:10491012.
   PubMed Web of Science ®Google Scholar
• van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R, Tensen CP.et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res 2004; 64:5578-86; PMID:15313894; http://dx.doi.org/10.1158/0008-5472.CAN-04-1253
   PubMed Web of Science ®Google Scholar
• Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C, Eriksen KW, Woetmann A, Kaestel CG, Nissen MH. et al. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia 2004; 18:1288-95; PMID:15141228; http://dx.doi.org/10.1038/sj.leu.2403385
   PubMed Web of Science ®Google Scholar
• Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 2001; 15:787-93; PMID:11368440; http://dx.doi.org/10.1038/sj.leu.2402093
   PubMed Web of Science ®Google Scholar
• Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Röpke C, Odum N. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 1999; 13:735-8; PMID:10374878; http://dx.doi.org/10.1038/sj.leu.2401415
   PubMed Web of Science ®Google Scholar
• van Kester MS, Out-Luiting JJ, von dem Borne PA, Willemze R, Tensen CP, Vermeer MH. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells. J invest dermatol 2008; 128:1691-5; PMID:18200050; http://dx.doi.org/10.1038/sj.jid.5701246
   PubMed Web of Science ®Google Scholar
• Zhang C, Li B, Gaikwad AS, Haridas V, Xu Z, Gutterman JU, Duvic M. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J invest dermatol 2008; 128:2728-35; PMID:18496567; http://dx.doi.org/10.1038/jid.2008.138
   PubMed Web of Science ®Google Scholar
• van der Fits L, Out-Luiting JJ, van Leeuwen MA, Samsom JN, Willemze R, Tensen CP, Vermeer MH. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sezary syndrome. J invest dermatol 2012; 132:440-7; PMID:21938013; http://dx.doi.org/10.1038/jid.2011.293
   PubMed Web of Science ®Google Scholar
• van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH, Willemze R, Tensen CP, Vermeer MH. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome. J invest dermatol 2011; 131:762-8; PMID:21085192; http://dx.doi.org/10.1038/jid.2010.349
   PubMed Web of Science ®Google Scholar
• Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Lovato P, Labuda T, Eriksen KW, Zhang Q, Becker JC, Ødum N. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia 2006; 20:1759-66; PMID: 16932349; http://dx.doi.org/10.1038/sj.leu.2404350
   PubMed Web of Science ®Google Scholar
• Abraham RM, Zhang Q, Odum N, Wasik MA. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Cancer biol ther 2011; 12:1019-22; PMID:22236880; http://dx.doi.org/10.4161/cbt.12.12.18144
   PubMed Web of Science ®Google Scholar
• Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C, Wasik M, Ødum N. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia 2005; 19:209-13; PMID:15618960; http://dx.doi.org/10.1038/sj.leu.2403610
   PubMed Web of Science ®Google Scholar
• Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J exp med 2001; 193:1087-96; PMID:11342593; http://dx.doi.org/10.1084/jem.193.9.1087
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, Nadler JL. Autoimmune diabetes is blocked in Stat4-deficient mice. J autoimmun 2004; 22:191-200; PMID:15041039; http://dx.doi.org/10.1016/j.jaut.2003.08.006
   PubMed Web of Science ®Google Scholar
• Krejsgaard T, Ralfkiaer U, Clasen-Linde E, Eriksen KW, Kopp KL, Bonefeld CM, Geisler C, Dabelsteen S, Wasik MA, Ralfkiaer E. et al. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway. J invest dermatol 2011; 131:1331-8; PMID:21346774; http://dx.doi.org/10.1038/jid.2011.27
   PubMed Web of Science ®Google Scholar
• Krejsgaard T, Litvinov IV, Wang Y, Xia L, Willerslev-Olsen A, Koralov SB, Kopp KL, Bonefeld CM, Wasik MA, Geisler C. et al. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma. Blood 2013; 122:943-50; PMID:23801634; http://dx.doi.org/10.1182/blood-2013-01-480889
   PubMed Web of Science ®Google Scholar
• Wong HK. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma. Discov Med 2013; 16:71-8; PMID:23998443
   PubMed Web of Science ®Google Scholar
• Zhang C, Richon V, Ni X, Talpur R, Duvic M. Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J invest dermatol 2005; 125:1045-52; PMID:16297208; http://dx.doi.org/10.1111/j.0022-202X.2005.23925.x
   PubMed Web of Science ®Google Scholar
• Hymes KB. The role of histone deacetylase inhibitors in the treatment of patients with cutaneous T-cell lymphoma. Clin Lymphoma Myeloma Leuk 2010; 10:98-109; PMID:20371442; http://dx.doi.org/10.3816/CLML.2010.n.014
   PubMed Web of Science ®Google Scholar
• Kaltoft K, Bisballe S, Dyrberg T, Boel E, Rasmussen PB, Thestrup-Pedersen K. Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In vitro cell develop biol : j Tissue Culture Assoc 1992; 28A:161-7; PMID:1582990; http://dx.doi.org/10.1007/BF02631086
   PubMed Web of Science ®Google Scholar
• Kopp KL, Ralfkiaer U, Nielsen BS, Gniadecki R, Woetmann A, Odum N, Ralfkiaer E. Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013; 121:1020-4; PMID:24033365; http://dx.doi.org/10.1111/apm.12162
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin cancer res : an official j Am Assoc Cancer Res 2004; 10:7252-9; PMID:15534099; http://dx.doi.org/10.1158/1078-0432.CCR-04-0713
   PubMed Web of Science ®Google Scholar
• Ciree A, Michel L, Camilleri-Broet S, Jean Louis F, Oster M, Flageul B, Senet P, Fossiez F, Fridman WH, Bachelez H. et al. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome). In j cancer J int du cancer 2004; 112:113-20; PMID:15305382; http://dx.doi.org/10.1002/ijc.20373
   PubMed Web of Science ®Google Scholar
• Willerslev-Olsen A, Litvinov IV, Fredholm SM, Petersen DL, Sibbesen NA, Gniadecki R, Zhang Q, Bonefeld CM, Wasik MA, Geisler C. et al. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell cycle 2014; 13:1306-12; PMID:24621498; http://dx.doi.org/10.4161/cc.28256
   PubMed Web of Science ®Google Scholar
• Nishikomori R, Usui T, Wu CY, Morinobu A, O'Shea JJ, Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J immunol 2002; 169:4388-98; PMID:12370372; http://dx.doi.org/10.4049/jimmunol.169.8.4388
   PubMed Web of Science ®Google Scholar
• Lawless VA, Zhang S, Ozes ON, Bruns HA, Oldham I, Hoey T, Grusby MJ, Kaplan MH. Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J immunol 2000; PMID:11120802; 165:6803-8; http://dx.doi.org/10.4049/jimmunol.165.12.6803
   PubMed Web of Science ®Google Scholar
• Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996; 382:174-7; PMID:8700209; http://dx.doi.org/10.1038/382174a0
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Kupper TS, Sasseville D. The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression. Exp dermatol 2012; 21:964-6; PMID:23171462; http://dx.doi.org/10.1111/exd.12039
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Zhou Y, Kupper TS, Sasseville D. Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma. Leuk lymphoma 2012; 54(3):653-4; PMID:22856870; http://dx.doi.org/10.3109/10428194.2012.717695
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S. et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713-22; PMID:17540844; http://dx.doi.org/10.1182/blood-2007-03-055749
   PubMed Web of Science ®Google Scholar
• Zhang C, Hazarika P, Ni X, Weidner DA, Duvic M. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin cancer res : an official j Am Assoc Cancer Res 2002; 8:1234-40; PMID:12006543
   PubMed Web of Science ®Google Scholar
• Bunn PA, Jr., Foss FM. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl 1996; 24:12-23; PMID:8806090; http://dx.doi.org/10.1002/jcb.240630503
   PubMedGoogle Scholar
• Chen TR. Karyotypic derivation of H9 cell line expressing human immunodeficiency virus susceptibility. J Natl Cancer Inst 1992; 84:1922-6; PMID:1460674; http://dx.doi.org/10.1093/jnci/84.24.1922
   PubMedGoogle Scholar
• Abrams JT, Lessin S, Ghosh SK, Ju W, Vonderheid EC, Nowell P, Murphy G, Elfenbein B, DeFreitas E. A clonal CD4-positive T-cell line established from the blood of a patient with Sezary syndrome. J invest dermatol 1991; 96:31-7; PMID:1987293; http://dx.doi.org/10.1111/1523-1747.ep12514693
   PubMed Web of Science ®Google Scholar
• Kaltoft K, Bisballe S, Rasmussen HF, Thestrup-Pedersen K, Thomsen K, Sterry W. A continuous T-cell line from a patient with Sezary syndrome. Archdermatol res 1987; 279:293-8; PMID:3498444; http://dx.doi.org/10.1007/BF00431220
   PubMed Web of Science ®Google Scholar
• Starkebaum G, Loughran TP, Jr., Waters CA, Ruscetti FW. Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor. Int j cancer J int du cancer 1991; 49:246-53; PMID:1879969; http://dx.doi.org/10.1002/ijc.2910490218
   PubMed Web of Science ®Google Scholar
• Wasik MA, Seldin DC, Butmarc JR, Gertz R, Marti R, Maslinski W, Kadin ME. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. Leukemia & lymphoma 1996; 23:125-36; PMID:9021695; http://dx.doi.org/10.3109/10428199609054811
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, Isaacs JT. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res 2006; 66:8598-607; PMID:16951173; http://dx.doi.org/10.1158/0008-5472.CAN-06-1228
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-86; PMID:10547847
   PubMedGoogle Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3(7): research0034.1-11; PMID:12184808; http://dx.doi.org/10.1186/gb-2002-3-7-research0034
   PubMed Web of Science ®Google Scholar
• Kaplan ELaM, P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81; http://dx.doi.org/10.1080/01621459.1958.10501452
   Web of Science ®Google Scholar
• Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004; 10:1507-17; PMID:15383676; http://dx.doi.org/10.1261/rna.5248604
   PubMed Web of Science ®Google Scholar